Department of Family and Community Medicine, University of California, San Francisco, USA.
Milbank Q. 2009 Dec;87(4):863-902. doi: 10.1111/j.1468-0009.2009.00582.x.
Legislatures and executive branch agencies in the United States and other nations are increasingly using reviews of the medical literature to inform health policy decisions. To clarify these efforts to give policymakers evidence of medical effectiveness, this article discusses the California Health Benefits Review Program (CHBRP). This program, based at the University of California, analyzes the medical effectiveness of health insurance benefit mandate bills for the California legislature, as well as their impact on cost and public health.
This article is based on the authors' experience reviewing benefit mandate bills for CHBRP and findings from evaluations of the program. General observations are illustrated with examples from CHBRP's reports. Information about efforts to incorporate evidence into health policymaking in other states and nations was obtained through a review of published literature.
CHBRP produces reports that California legislators, legislative staff, and other major stakeholders value and use routinely in deliberations about benefit mandate bills. Where available, the program relies on previously published meta-analyses and systematic reviews to streamline the review of the medical literature. Faculty and staff responsible for the medical effectiveness sections of CHBRP's reports have learned four major lessons over the course of the program's six-year history: the need to (1) recognize the limitations of the medical literature, (2) anticipate the need to inform legislators about the complexity of evidence, (3) have realistic expectations regarding the impact of medical effectiveness reviews, and (4) understand the consequences of the reactive nature of mandated benefit reviews.
CHBRP has demonstrated that it is possible to produce useful reviews of the medical literature within the tight time constraints of the legislative process. The program's reports have provided state legislators with independent analyses that allow them to move beyond sifting through conflicting information from proponents and opponents to consider difficult policy choices and their implications.
美国和其他国家的立法机构和行政部门越来越多地利用医学文献综述来为卫生政策决策提供信息。为了澄清这些努力,为政策制定者提供医学有效性的证据,本文讨论了加利福尼亚健康福利审查计划(CHBRP)。该计划由加利福尼亚大学运营,为加利福尼亚州立法机构分析健康保险福利授权法案的医学有效性及其对成本和公共卫生的影响。
本文基于作者为 CHBRP 审查福利授权法案的经验以及对该计划的评估结果。一般观察结果通过 CHBRP 报告中的示例进行说明。关于其他州和国家将证据纳入卫生决策制定工作的努力的信息是通过对已发表文献的审查获得的。
CHBRP 发布的报告受到加利福尼亚州立法者、立法工作人员和其他主要利益相关者的重视,并在审议福利授权法案时经常使用。在可行的情况下,该计划依赖先前发表的荟萃分析和系统评价来简化对医学文献的审查。负责 CHBRP 报告中医疗效果部分的教师和工作人员在该计划六年的历史中吸取了四个主要教训:(1)需要认识到医学文献的局限性,(2)预测需要向立法者通报证据的复杂性,(3)对医疗效果审查的影响有现实的期望,(4)了解强制性福利审查的反应性质的后果。
CHBRP 表明,在立法过程的严格时间限制内,有可能对医学文献进行有用的综述。该计划的报告为州立法者提供了独立的分析,使他们能够超越从支持者和反对者那里筛选相互矛盾的信息,考虑艰难的政策选择及其影响。